News & Events

Dispatches from the world of RMPs: Accent news and events

What’s "c/λ" at Accent?

September 3, 2019 Accent Therapeutics Appoints Shakti Narayan as Chief Executive Officer

March 27, 2019 Accent Presents "Elevated Cancer-Intrinsic Type I Interferon Signaling Confers a Dependency on the RNA Editor ADAR1" (GRC 2019)

October 26 - 30, 2019

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Accent presents two scientific posters highlighting its lead programs at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, October 26-30, in Boston, MA.

November 19 - 20, 2019

1st RNA Editing Summit

Our Vice President of Biology, Scott Ribich, presents "ADAR1 as a Therapeutic Target in Type I Interferon Signaling-High Cancer" at the 1st RNA Editing Summit, November 19-20, in Boston, MA.

November 20, 2019

Targeted Allosteric Modulators Summit

Our President & CSO, Bob Copeland, gives the Keynote Presentation "Allosteric Modulators - Where We Are and How We Got Here" at the Targeted Allosteric Modulators Summit, November 20, in Boston, MA.

December 2 - 4, 2019

2nd RNA-Targeted Drug Discovery Summit

Our Vice President of Molecular Discovery, Ann Boriack-Sjodin, presents "RMP-Targeted Cancer Drug Discovery" at the 2nd RNA-Targeted Drug Discovery Summit, December 2-4, in Boston, MA.

January 12 - 16, 2020

Noncoding RNAs: Mechanism, Function and Therapies

Our Vice President of Biology, Scott Ribich, presents "RNA-Modifying Proteins as Anticancer Targets" at the Keystone Symposium on Noncoding RNAs: Mechanism, Function and Therapies, January 12-16, in Whistler, British Columbia.